TCM
KRTX

TimesSquare Capital Management’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

TimesSquare Capital Management’s Portfolio KRTX Stock Details KRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1,600
Closed -$347K – 179
2023
Q2 		$347K Buy
+1,600
New +$347K 0.01% 173